COHR

Coherent Inc.

Price

$283.44

return (12m)

155.12%

p/e

74.48

p/bv

5.34

DIVIDEND YIELD

0.00%

COHR price

Coherent

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment COHR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.10%

3 months

-8.79%

1 year

155.12%

2 years

170.92%

5 years

390.38%

10 years

1,005.03%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals COHR

Valuation

P/E

74.48

Sector 1.07

Industry 3.44

P/BV

5.34

Sector 1.86

Industry 2.12

P/Revenue (PSR)

8.42

Sector 1.54

Industry 1.69

EV/EBITDA

132.97

Sector -45.27

Industry 1.81

EV/EBIT

191.46

Sector -48.49

Industry -3.96

P/EBITDA

38.44

Sector -31.51

Industry -53.51

P/EBIT

57.76

Sector -42.93

Industry -50.81

P/Total Assets

3.28

Sector 0.85

Industry 0.94

P/Net Current Assets

-440.37

Sector -25.71

Industry -10.60

P/Working Capital

14.73

Sector -4.14

Industry 2.66

EPS

4.13

Sector -0.70

Industry -0.60

BVPS

57.61

Sector 4.52

Industry 4.74

Efficiency

Gross Margin

37.50%

Sector 49.51%

Industry 50.68%

EBITDA Margin

22.49%

Sector -280.81%

Industry -57.47%

EBIT Margin

11.91%

Sector -19.82%

Industry -25.80%

Net Profit Margins

11.31%

Sector -24.01%

Industry -29.17%

Asset Turnover

0.11

Sector 0.13

Industry 0.15

Profitability

ROE

7.16%

Sector -23.78%

Industry -22.30%

ROA

4.40%

Sector -24.20%

Industry -24.15%

ROIC

7.63%

Sector -584.46%

Industry -96.49%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.43

Sector 1.91

Industry 1.98

Net Debt / EBITDA

2.67

Sector -23.21

Industry -2.21

Net Debt / EBIT

3.84

Sector -17.93

Industry -1.50

Net Debt / Equity

0.11

Sector -0.68

Industry -0.29

Gross Debt / Equity

0.29

Sector -0.72

Industry -0.82

Equity/Assets

0.61

Sector 0.46

Industry 0.47

Liabilities/Assets

0.39

Sector 0.50

Industry 0.52

Growth

5Y Revenue CAGR

17.39%

Sector -

Industry -

5Y Earnings CAGR

21.38%

Sector -

Industry -

Fundamentals COHR

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Coherent ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$283.44

Fair Value

$73.17

Upside

-74.19%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
COHR Coherent Inc.	$283.44	155.12%	0.00%	74.48	5.34	7.16%	11.31%
ABT Abbott Laboratories	$102.20	-19.92%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.07	0.39%	3.28%	21.29	2.19	10.29%	13.93%
BSX Boston Scientific Corp.	$43.13	-54.80%	0.00%	17.05	2.51	14.73%	17.49%
TMDX TransMedics Group Inc.	$79.38	-26.01%	0.00%	18.01	5.27	29.28%	22.69%
RMD ResMed Inc.	$234.61	-12.84%	1.07%	21.81	5.05	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$521.27	-15.40%	0.00%	35.95	25.41	70.67%	25.03%
SYK Stryker Corp.	$281.76	-21.68%	1.27%	28.21	4.38	15.55%	14.43%
PHG Koninklijke Philips NV	$24.82	-5.61%	4.20%	17.81	1.74	9.80%	6.30%
INMD InMode Ltd.	$14.33	-6.13%	0.00%	10.78	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$187.39	2.94%	2.30%	53.38	2.06	3.85%	6.29%
DXCM DexCom Inc.	$85.21	30.85%	0.00%	32.03	12.21	38.14%	20.12%
EW Edwards Lifesciences Corp.	$85.60	15.77%	0.00%	47.85	4.48	9.37%	15.43%
ALGN Align Technology Inc.	$141.41	12.41%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$27.86	-17.87%	2.88%	20.20	4.39	21.74%	9.20%
IRMD iRadimed Corporation	$89.76	26.66%	1.46%	48.20	10.92	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$92.30	-1.26%	1.08%	21.13	1.35	6.39%	9.48%
NOVT Novanta Inc.	$143.05	43.11%	0.00%	93.58	3.58	3.82%	6.00%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

COHR - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/17/2012	12/27/2012	1.00000000

ABOUT Coherent

Coherent Inc.

Average Investor10 user rating

4.0 (28 people)

United States

60 years

Founded: 1966

1990

Time since IPO - 36 years

4.875

Employees

Coherent Inc. (United States) is listed on the NYSE and has a market capitalization of $59.96 billion, with shareholders equity totaling $11.24 billion.

The company employs approximately 4.875 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Coherent Inc. reported $7.12 billion in revenue, generating net income of $805.00 million.

Key financial metrics include a P/E ratio of 74.48, a price-to-book (P/B) ratio of 5.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker COHR.

Market cap

$59.96 billion

Net worth

$11.24 billion

$11,238,200,000.00

Assets

$18.30 billion

$18,299,852,000.00

Total Shares Outstanding

195.08 million

195,083,000

Average Daily Trading Volume

$7.00 million

$7,000,962.00

Sector

Health

Industry

Medical Supplies and Equipment

COHR

revenue by Business Segment Coherent

COHR revenue and profits

Financial Results COHR

DRAG THE FRAME TO SEE MORE DATA

COHR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$87.73 16,27% (12M)

P/E

22.64

3.07%

ROE

6.12%

P/BV

1.39

CI - Cigna

$283.40 --1,90% (12M)

P/E

10.91

2.19%

ROE

16.04%

P/BV

1.75

CNC - Centene

$69.20 90,32% (12M)

P/E

-6.39

0.00%

ROE

-22.53%

P/BV

1.44

HUM - Humana

$424.68 59,34% (12M)

P/E

40.85

0.81%

ROE

6.63%

P/BV

2.71

SNY - Sanofi

$39.43 --16,02% (12M)

P/E

3.76

4.41%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$246.60 32,11% (12M)

P/E

29.77

2.03%

ROE

24.76%

P/BV

7.37

LLY - Eli Lilly

$1,168.32 43,48% (12M)

P/E

39.18

0.57%

ROE

78.84%

P/BV

30.89

HCA - HCA Healthcare

$460.26 12,61% (12M)

P/E

14.42

0.68%

ROE

-213.15%

P/BV

-30.74